logo
logo

Post Acute Analytics Announces Series B Funding Led by Concord Health Partners and Dorilton Capital

Jan 25, 2021•over 4 years ago

Round Type

series b

Dallas

Description

Post Acute Analytics (“PAA”) www.paanalytics.com, a provider of end-to-end solutions that empower healthcare providers and payors to positively impact the total quality and cost of care, today announced the Company has closed a Series B round of funding. The round was co-led by Concord Health Partners, through its AHA Innovation Development Fund, and Dorilton Capital. Existing investors including Generator Ventures also participated in the round.

Company Information

Company

Concord Health Partners

Location

Dallas, Georgia, United States

About

Concord Health Partners is a healthcare-focused investment firm with a strategic approach that aligns interests between investors and portfolio companies. Concord is primarily focused on investing in companies that have the potential to enhance the value of care through technologies and solutions that lower costs, improve quality and/or expand access to care. The firm, in partnership with the American Hospital Association, sponsors and manages the AHA Innovation Development Fund, a venture capital fund formed to help hospitals and health systems advance health care and better serve their patients and communities.